News | May 19, 2026
Dyno unveils next-gen AI-designed gene delivery capsids targeting brain & muscle
This positions its platform as a rapidly evolving engine for next-generation genetic medicine
This positions its platform as a rapidly evolving engine for next-generation genetic medicine
The decision marks a significant expansion for Pfizer’s once-weekly injectable therapy
The company informed stock exchanges that the appellate authority has set aside the GST demand along with applicable interest and penalty
Company plans to appeal against CGST order related to alleged inadmissible input tax credit claims
The renewal covers two versions of the IQOS device and three HEETS tobacco variants
The trials -- ELOWEN-1 and ELOWEN-2 -- are designed to evaluate the drug in people living with lupus who experience active skin manifestations
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
Former Wavemaker executive to lead media strategy and digital transformation agenda
Safety was equally impressive. ENV-294 was well tolerated
The company’s broader OX2R portfolio includes clinical and preclinical assets with potential applications across neurological, neurodegenerative, and neuropsychiatric conditions
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
